Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Rating of "Moderate Buy" from Analysts

Key Points

• Addus HomeCare received a “Moderate Buy” consensus rating from 11 analysts, with five buys, one strong buy, four holds and one sell. The average 12-month price target is $128, compared with the stock’s reported price of $118.06.
• Recent analyst actions were mixed: Bank of America cut its price target to $125 and maintained a neutral rating, while Citigroup downgraded the stock to neutral; RBC raised its target to $134 and retained an outperform rating.
• Addus reported quarterly earnings of $1.73 per share, beating expectations of $1.70, while revenue rose 8% year over year to $377.41 million. Institutional investors own approximately 95.35% of the company’s shares.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $128.00.

A number of research firms recently commented on ADUS. Raymond James Financial set a $125.00 target price on shares of Addus HomeCare in a research report on Monday. Bank of America restated a "neutral" rating and issued a $125.00 price objective (down from $140.00) on shares of Addus HomeCare in a research note on Monday. Citigroup lowered Addus HomeCare from a "market outperform" rating to a "neutral" rating in a report on Monday. Royal Bank Of Canada lifted their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 5th. Finally, Weiss Ratings raised Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, July 9th.

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Dixon sold 288 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider owned 44,371 shares of the company's stock, valued at $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

Large investors have recently modified their holdings of the company. Leeward Investments LLC MA raised its stake in Addus HomeCare by 9.4% during the 1st quarter. Leeward Investments LLC MA now owns 120,857 shares of the company's stock valued at $11,318,000 after acquiring an additional 10,414 shares during the last quarter. Summit Creek Advisors LLC purchased a new position in shares of Addus HomeCare in the 2nd quarter valued at approximately $8,552,000. Bank of America Corp DE grew its stake in shares of Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company's stock valued at $30,252,000 after purchasing an additional 32,714 shares during the last quarter. TimesSquare Capital Management LLC acquired a new position in shares of Addus HomeCare in the second quarter valued at approximately $31,502,000. Finally, SG Americas Securities LLC increased its holdings in shares of Addus HomeCare by 176.0% in the first quarter. SG Americas Securities LLC now owns 27,303 shares of the company's stock valued at $2,557,000 after purchasing an additional 17,411 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Stock Performance

Shares of ADUS opened at $118.06 on Friday. The stock has a 50 day moving average price of $116.49 and a 200 day moving average price of $103.60. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The company has a market capitalization of $2.20 billion, a price-to-earnings ratio of 20.71, a price-to-earnings-growth ratio of 1.69 and a beta of 0.86. Addus HomeCare has a 52-week low of $87.95 and a 52-week high of $124.43.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts' consensus estimates of $1.70 by $0.03. The company had revenue of $377.41 million for the quarter, compared to analysts' expectations of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm's revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter last year, the company earned $1.49 earnings per share. Research analysts predict that Addus HomeCare will post 6.3 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults, people with disabilities and individuals with chronic or complex medical needs. The company operates through three primary service lines: personal care, hospice and home health.

Its personal care services include assistance with daily living activities, such as bathing, dressing, meal preparation and household tasks. Addus also provides hospice care for individuals with terminal illnesses, as well as home health services that may include skilled nursing, therapy and other clinical support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.